Aaron M Etra, MD
img_Aaron M Etra
ASSISTANT PROFESSOR | Medicine, Hematology and Medical Oncology
Are you a patient?
Specialties
Internal Medicine, Cancer (Oncology), Hematology-Oncology

MD, Yeshiva University Albert Einstein College of Medicine

Internship, Internal Medicine, Mount Sinai Beth Israel

Residency, Internal Medicine, Mount Sinai Beth Israel

Fellowship, Hematology & Oncology, Mount Sinai Hospital and Medical Center

Certifications

American Board of Internal Medicine
Publications

Selected Publications

A Day 14 Endpoint for Acute GVHD Clinical Trials. Nikolaos Spyrou, Yu Akahoshi, Steven Kowalyk, George Morales, Rahnuma Beheshti, Paibel Aguayo-Hiraldo, Monzr M. Al Malki, Francis Ayuk, Peter Bader, Janna Baez, Alexandra Capellini, Hannah Choe, Zachariah DeFilipp, Matthias Eder, Gilbert Eng, Aaron Etra, Sigrun Gleich, Stephan A. Grupp, Elizabeth Hexner, Matthias Hoepting, William J. Hogan, Stelios Kasikis, Nikolaos Katsivelos, Alina Khan, Carrie L. Kitko, Sabrina Kraus, Deukwoo Kwon, Pietro Merli, Joseph Portelli, Muna Qayed, Ran Reshef, Tal Schechter, Ingrid Vasova, Matthias Wölfl, Kitsada Wudhikarn, Rachel Young, Ernst Holler, Yi Bin Chen, Ryotaro Nakamura, John E. Levine, James L.M. Ferrara. Transplantation and Cellular Therapy

Phase 2 study of natalizumab plus standard corticosteroid treatment for high-risk acute graft-versus-host disease. Monzr M. Al Malki, Kaitlyn London, Janna Baez, Yu Akahoshi, William J. Hogan, Aaron Etra, Hannah Choe, Elizabeth Hexner, Amelia Langston, Sunil Abhyankar, Doris M. Ponce, Zachariah DeFilipp, Carrie L. Kitko, Kehinde Adekola, Ran Reshef, Francis Ayuk, Alexandra Capellini, Chantiya Chanswangphuwana, Matthias Eder, Gilbert Eng, Isha Gandhi, Stephan Grupp, Sigrun Gleich, Ernst Holler, Nora Rebeka Javorniczky, Stelios Kasikis, Steven Kowalyk, George Morales, Umut Özbek, Wolf Rösler, Nikolaos Spyrou, Gregory Yanik, Rachel Young, Yi Bin Chen, Ryotaro Nakamura, James L.M. Ferrara, John E. Levine. Blood advances

The utility of biomarkers in acute GVHD prognostication. Nikolaos Spyrou, Yu Akahoshi, Francis Ayuk, Ernst Holler, Hannah Choe, Aaron Etra, William J. Hogan, Wolf Rösler, Elizabeth Hexner, Zachariah DeFilipp, Ran Reshef, Chantiya Chanswangphuwana, Muna Qayed, Sabrina Kraus, Matthias Eder, Nora Rebeka Javorniczky, Stephan A. Grupp, Carrie L. Kitko, Pietro Merli, Paibel Aguayo-Hiraldo, Matthias Wölfl, Janna Baez, Rahnuma Beheshti, Gilbert Eng, Sigrun Gleich, Nikolaos Katsivelos, Alina Khan, Steven Kowalyk, George Morales, Rachel Young, Ryotaro Nakamura, Yi Bin Chen, John E. Levine, James L.M. Ferrara. Blood advances

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Etra has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.